QORVO INC. - COMMON STOCK

Qorvo® to Present at the Raymond James 43rd Annual Institutional Investors Conference

28 Feb 2022 05:00:02 By Nasdaq GlobeNewswire

Qorvo Biotechnologies Awarded $4.1 Million National Institutes of Health Contract for SARS-CoV-2/ Flu Combo and Antigen Pooling

07 Feb 2022 05:00:00 By Nasdaq GlobeNewswire

Qorvo® Announces Fiscal 2022 Third Quarter Financial Results

02 Feb 2022 13:00:00 By Nasdaq GlobeNewswire

Qorvo® to Webcast Quarterly Earnings Conference Call on February 2, 2022

19 Jan 2022 05:00:01 By Nasdaq GlobeNewswire

Qorvo® Simplifies Wi-Fi 6E System Design with the First Single FEM to Support 5.1 to 7.1 GHz Bands

06 Jan 2022 05:00:03 By Nasdaq GlobeNewswire

Qorvo® Delivers Ultra-Wideband in Google® Pixel 6 Pro

20 Dec 2021 05:00:00 By Nasdaq GlobeNewswire

Qorvo® Announces Closing of $500 Million Senior Notes Offering

14 Dec 2021 08:22:01 By Nasdaq GlobeNewswire

Qorvo® Announces Pricing of $500 Million Senior Notes Offering

09 Dec 2021 12:14:39 By Nasdaq GlobeNewswire

Qorvo® Announces Proposed Senior Notes Offering

09 Dec 2021 05:51:37 By Nasdaq GlobeNewswire

Qorvo® to Present at Barclays Global Technology, Media and Telecommunications Virtual Conference

01 Dec 2021 05:00:02 By Nasdaq GlobeNewswire

Qorvo® Biotechnologies Omnia™ SARS-CoV-2 Antigen Test Detects Delta and Other Circulating Variants in Two Studies

10 Nov 2021 05:00:02 By Nasdaq GlobeNewswire

Qorvo® Acquires United Silicon Carbide (UnitedSiC), a Leading Provider of Silicon Carbide Power Semiconductors

03 Nov 2021 13:30:00 By Nasdaq GlobeNewswire

Qorvo® Announces Appointment of Philip Chesley as President of Infrastructure & Defense Products

03 Nov 2021 13:10:00 By Nasdaq GlobeNewswire

Qorvo® Announces Fiscal 2022 Second Quarter Financial Results

03 Nov 2021 13:01:01 By Nasdaq GlobeNewswire

Qorvo® to Webcast Quarterly Earnings Conference Call on November 3, 2021

20 Oct 2021 05:00:01 By Nasdaq GlobeNewswire

Qorvo® Announces Fiscal 2022 First Quarter Financial Results

04 Aug 2021 13:00:00 By Nasdaq GlobeNewswire

Qorvo Biotechnologies Omnia™ SARS-CoV-2 Antigen Test Platform Validated in National Institutes of Health (NIH) Funded Study

28 Jul 2021 13:01:00 By Nasdaq GlobeNewswire

Qorvo® to Webcast Quarterly Earnings Conference Call on August 4, 2021

21 Jul 2021 05:00:01 By Nasdaq GlobeNewswire

Qorvo Advances Radar Architecture with Reconfigurable Dual-band GaN Power Amplifier MMICs

21 Jun 2021 05:00:01 By Nasdaq GlobeNewswire

Qorvo® Solutions Interoperable with Apple* U1 Chip for New Ultra-Wideband Enabled Experiences

07 Jun 2021 13:01:00 By Nasdaq GlobeNewswire